Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.
3.
4.

Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity.

Stefan N, Kovacs P, Stumvoll M, Hanson RL, Lehn-Stefan A, Permana PA, Baier LJ, Tataranni PA, Silver K, Bogardus C.

Diabetes. 2003 Jun;52(6):1544-50.

5.

Polymorphism of stress protein HSP70-2 gene in Tunisians: susceptibility implications in type 2 diabetes and obesity.

Zouari Bouassida K, Chouchane L, Jellouli K, Chérif S, Haddad S, Gabbouj S, Danguir J.

Diabetes Metab. 2004 Apr;30(2):175-80.

6.
7.

Analysis of the hexokinase II gene in subjects with insulin resistance and NIDDM and detection of a Gln142-->His substitution.

Vidal-Puig A, Printz RL, Stratton IM, Granner DK, Moller DE.

Diabetes. 1995 Mar;44(3):340-6.

PMID:
7883122
8.

Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.

Tavares V, Hirata RD, Rodrigues AC, Monte O, Salles JE, Scalissi N, Speranza AC, Hirata MH.

Diabetes Obes Metab. 2005 Sep;7(5):605-11.

PMID:
16050954
9.

Polymorphism in the sorbin and SH3-domain-containing-1 (SORBS1) gene and the risk of brain infarction in the Japanese population: the Fukuoka Stroke Registry and the Hisayama study.

Hagiwara N, Kitazono T, Kamouchi M, Kuroda J, Ago T, Hata J, Ninomiya T, Ooboshi H, Kumai Y, Yoshimura S, Tamaki K, Fujii K, Nagao T, Okada Y, Toyoda K, Nakane H, Sugimori H, Yamashita Y, Wakugawa Y, Kubo M, Tanizaki Y, Kiyohara Y, Ibayashi S, Iida M; Fukuoka Stroke Registry; Hisayama study.

Eur J Neurol. 2008 May;15(5):481-6. doi: 10.1111/j.1468-1331.2008.02105.x.

PMID:
18394047
10.

A single nucleotide polymorphism in exon 7 of sorbin and SH3-domain-containing-1 (SORBS1) in Korean PCOS patients.

Park JM, Gu BH, Lee EJ, Kim JY, Choi SW, Baek KH.

Mol Med Rep. 2008 Jan-Feb;1(1):93-7.

PMID:
21479384
11.

Organization of the human carboxypeptidase E gene and molecular scanning for mutations in Japanese subjects with NIDDM or obesity.

Utsunomiya N, Ohagi S, Sanke T, Tatsuta H, Hanabusa T, Nanjo K.

Diabetologia. 1998 Jun;41(6):701-5.

PMID:
9662053
12.

Detection of mutations in the insulin receptor gene in patients with insulin resistance by analysis of single-stranded conformational polymorphisms.

Kim H, Kadowaki H, Sakura H, Odawara M, Momomura K, Takahashi Y, Miyazaki Y, Ohtani T, Akanuma Y, Yazaki Y, et al.

Diabetologia. 1992 Mar;35(3):261-6.

PMID:
1563582
15.

Polymorphism screening of the insulin receptor-related receptor gene (INSRR) on 1q in Pima Indians.

Wolford JK, Thameem F, Bogardus C, Prochazka M.

Mol Cell Probes. 2001 Aug;15(4):223-7.

PMID:
11513557
17.

High frequency of polymorphism but no mutations found in the GLUT1 glucose transporter gene in NIDDM and familial obesity by SSCP analysis.

Baroni MG, D'Andrea MP, Capici F, Buzzetti R, Cavallo MG, Fallucca F, Giovannini C, Pozzilli P.

Hum Genet. 1998 Apr;102(4):479-82.

PMID:
9600248
18.

Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance.

Laakso M, Malkki M, Kekäläinen P, Kuusisto J, Deeb SS.

Diabetologia. 1995 May;38(5):617-22.

PMID:
7489847
19.

Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study.

Sentinelli F, Romeo S, Arca M, Filippi E, Leonetti F, Banchieri M, Di Mario U, Baroni MG.

Diabetes. 2002 Mar;51(3):860-2. Erratum in: Diabetes 2002 Jun;51(6):1992.

20.

Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients.

Marchal-Victorion S, Vionnet N, Escrieut C, Dematos F, Dina C, Dufresne M, Vaysse N, Pradayrol L, Froguel P, Fourmy D.

Pharmacogenetics. 2002 Jan;12(1):23-30.

PMID:
11773861
Items per page

Supplemental Content

Write to the Help Desk